The C57BL/6 genetic background confers cardioprotection in iron-overloaded mice

Blood Transfusion

Volumn 11, Issue 1, 2013, Pages 88-93

  Musumeci, Marco ^a   Maccari, Sonia ^a   Sestili, Paola ^a   Massimi, Alessia ^a   Corritore, Elisa ^a   Marano, Giuseppe ^a   Catalano, Liviana ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b National Blood Centre   (Italy)

Author keywords

Beta blockers; Heart failure; Iron overload; Packed red blood cells; Transfusion therapy

Indexed keywords

IRON; IRON DEXTRAN; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; C57BL 6 MOUSE; CONTROLLED STUDY; FLUID INTAKE; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART PERFORMANCE; HEART PROTECTION; HISTOLOGY; IRON OVERLOAD; MALE; MOUSE; NONHUMAN; TRANSTHORACIC ECHOCARDIOGRAPHY; WEIGHT GAIN;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CALCIUM CHANNELS, L-TYPE; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; HEMATINICS; IRON; IRON OVERLOAD; IRON-DEXTRAN COMPLEX; MALE; MICE; MYOCARDIUM; PROPRANOLOL; SPECIES SPECIFICITY;

EID: 84872234644     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0176-11     Document Type: Article

References (10)

1. Porter JB. Practical management of iron overload. Br J Haematology 2001; 115: 239-52. (Pubitemid 34203484)
2. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89:1187-93. (Pubitemid 39390442)
3. Anderson LJ, Wonke B, Prescott E, et al. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002; 360: 516-20. (Pubitemid 35232104)
4. Oudit GY, Sun H, Trivieri MG, et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003; 9: 1187-94. (Pubitemid 37173704)
5. van der Heyden MA, Wijnhoven TJ, Opthof T. Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels. Cardiovasc Res 2005; 65: 28-39. (Pubitemid 40038476)
6. Tsay J, Yang Z, Ross FP, et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood. 2010; 116: 2582-9.
7. Marano G, Vergari A, Catalano L, et al. Na/H exchange inhibition attenuates left ventricular remodeling and preserves systolic function in pressure-overloaded hearts. Br J Pharmacol 2004; 141: 526-32. (Pubitemid 38297015)
8. Oudit GY, Trivieri MG, Khaper N, et al. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 2004; 109: 1877-85. (Pubitemid 38509123)
9. Azzi M, Charest PG, Angers S, et al. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 2003; 100: 11406-11. (Pubitemid 37205948)
10. Tzingounis AV, von Zastrow M, Yudowski GA. Beta-blocker drugs mediate calcium signaling in native central nervous system neurons by beta-arrestin-biased agonism. Proc Natl Acad Sci USA 2010; 107: 21028-33.